SlideShare une entreprise Scribd logo
1  sur  61
Arun Chawla, MD
[object Object],[object Object],[object Object],[object Object],[object Object]
Copyright ©2010 American Society of Hematology. Copyright restrictions may apply. Ghobrial, I. M. et al. ASH-SAP 2010;2010:581-604 Table 20-1 Diagnostic criteria for monoclonal gammopathies
[object Object],[object Object],[object Object],[object Object],Although LCs (and HCs) have many structural similarities, they also possess a unique sequence that may be responsible for physicochemical peculiarities, hence their deposition in tissue or interaction with tissue constituents. Biochemical studies have identified specific Ig structural abnormalities that are associated with MM, MIDD, and amyloidosis -
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],n Physiology
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
Copyright ©2006 American Society of Nephrology
Protein cast obstructs tubule with syncitial giant cell reaction around it
[object Object],[object Object],[object Object]
Myeloma cast nephropathy demonstrating light-chain restriction in the casts.  Copyright ©2006 American Society of Nephrology Korbet, S. M. et al. J Am Soc Nephrol 2006;17:2533-2545 The cast stained with  Ig light chain κ (A) shows bright (3+) staining. The same cast stained in a serial section for  light chain λ (B) is negative.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object]
identify FLCs at a minimum concentration of 100-150mg/l. Insufficient to identify non secretory or oligo-secretory myeloma
Technique uses purified polyclonal antibodies against free k and λ light chains which  are precoated to latex particles and then analyzed by nephlometric assay for quantification. Permits detection of light chain to a level of 2-4mg/l.
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
Median survival 62 mo Median survival 44 mo Median survival 29 mo
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
EUROPEAN JOURNAL OF CANCER 4 2 ( 2 0 0 6 )
Leung et al. KI (2008)
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
Pts got PD in control and HD in PPx group Eleven patients were randomized to receive PLEX. They noted no differences in the overall renal recovery rate however, in a subgroup analysis of the dialysis patients, renal recovery occurred only in those who received PLEX. Small study.  compromised by the use of a composite outcome which disadvantaged PLEX because patient who died with improved renal function and those with eGFR <30 were considered failures. the renal pathology was not verified due to the low biopsy rate. Finally, no method was employed to assess the adequacy of treatment.
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
Mesangial & Cap loops amyloid deposits. Arteriolar wall with amyloid.
www.pathology.vcu.edu
www.pathology.vcu.edu IMMUNOHISTOCHEMICAL STAININGS To differentiate amyloid AL and AA, specific antibodies can also be used.
Copyright ©2006 American Society of Nephrology randomly arranged, nonbranching fibrils with an average diameter of 90 to 110 Å Renal amyloidosis, ultrastructural appearance
www.pathology.vcu.edu Amyloid p glycoprotein component present in basement membrane binds the amyloid fibrils
[object Object],[object Object],[object Object],[object Object],Gertz et al. Am J Clin Path 1990
Treatment ,[object Object],Current HematologicMalignancy Reports 2009, 4:91–98
[object Object],[object Object],[object Object]
[object Object],[object Object]
 
 
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
Copyright ©2006 American Society of Nephrology Korbet, S. M. et al. J Am Soc Nephrol 2006;17:2533-2545 Monoclonal Ig deposition disease (MIDD) with diffuse and nodular glomerulosclerosis
Copyright ©2006 American Society of Nephrology Korbet, S. M. et al. J Am Soc Nephrol 2006;17:2533-2545 MIDD showing light chain restriction by immunofluorescence microscopy
inconstant electron-dense, subendothelial, granular, punctuate deposits that may diffusely infiltrate the basal lamina.
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Approach to thrombocytopenia.pptx
Approach to  thrombocytopenia.pptxApproach to  thrombocytopenia.pptx
Approach to thrombocytopenia.pptx
Pritish Chandra Patra
 
Cytogenetic analysis in Hematological Malignancies
Cytogenetic analysis in Hematological MalignanciesCytogenetic analysis in Hematological Malignancies
Cytogenetic analysis in Hematological Malignancies
spa718
 
Membranous nephropathy
Membranous nephropathyMembranous nephropathy
Membranous nephropathy
Vishal Golay
 

Tendances (20)

Microcytic hypochromic anemia
Microcytic hypochromic anemiaMicrocytic hypochromic anemia
Microcytic hypochromic anemia
 
Thrombotic microangiopathy
Thrombotic microangiopathyThrombotic microangiopathy
Thrombotic microangiopathy
 
IgA nephropathy
IgA nephropathyIgA nephropathy
IgA nephropathy
 
Iron refractory iron deficiency anemia1
Iron refractory iron deficiency anemia1Iron refractory iron deficiency anemia1
Iron refractory iron deficiency anemia1
 
MDS/MPN (2021)
MDS/MPN (2021)MDS/MPN (2021)
MDS/MPN (2021)
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
Approach to thrombocytopenia.pptx
Approach to  thrombocytopenia.pptxApproach to  thrombocytopenia.pptx
Approach to thrombocytopenia.pptx
 
Plasma Cell Disorders
Plasma Cell DisordersPlasma Cell Disorders
Plasma Cell Disorders
 
Thrombotic Microangiopathy
Thrombotic MicroangiopathyThrombotic Microangiopathy
Thrombotic Microangiopathy
 
Cytogenetic analysis in Hematological Malignancies
Cytogenetic analysis in Hematological MalignanciesCytogenetic analysis in Hematological Malignancies
Cytogenetic analysis in Hematological Malignancies
 
Dyserythropoietic anaemia
Dyserythropoietic anaemiaDyserythropoietic anaemia
Dyserythropoietic anaemia
 
Membranous nephropathy
Membranous nephropathyMembranous nephropathy
Membranous nephropathy
 
An approach to a kidney biopsy manan
An approach to a kidney biopsy  mananAn approach to a kidney biopsy  manan
An approach to a kidney biopsy manan
 
Genetic Markers in AML
Genetic Markers in AMLGenetic Markers in AML
Genetic Markers in AML
 
Minimal residual disease
Minimal residual diseaseMinimal residual disease
Minimal residual disease
 
Microalbuminuria
MicroalbuminuriaMicroalbuminuria
Microalbuminuria
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
Chronic myelomonocytic leukemia (cmml)
Chronic myelomonocytic leukemia (cmml)Chronic myelomonocytic leukemia (cmml)
Chronic myelomonocytic leukemia (cmml)
 
Special stains
Special stainsSpecial stains
Special stains
 
Minimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemiaMinimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemia
 

En vedette

Renal Impairment in Multiple Myeloma
Renal Impairment in Multiple MyelomaRenal Impairment in Multiple Myeloma
Renal Impairment in Multiple Myeloma
Mohammed A Suwaid
 
High cut off dialysis and multiple myeloma
High cut off dialysis and multiple myelomaHigh cut off dialysis and multiple myeloma
High cut off dialysis and multiple myeloma
Sandeep Gopinath Huilgol
 
Classification And Diagnosis Of Diabetes
Classification And Diagnosis Of DiabetesClassification And Diagnosis Of Diabetes
Classification And Diagnosis Of Diabetes
PeninsulaEndocrine
 
Hypoglycemia
HypoglycemiaHypoglycemia
Hypoglycemia
Ortiz-C
 
Insulin presentation
Insulin presentationInsulin presentation
Insulin presentation
Ammar Akhtar
 

En vedette (20)

Renal Impairment in Multiple Myeloma
Renal Impairment in Multiple MyelomaRenal Impairment in Multiple Myeloma
Renal Impairment in Multiple Myeloma
 
Plasma Cell Dyscrasias & The Kidney (How they affect the kidney? When to susp...
Plasma Cell Dyscrasias & The Kidney (How they affect the kidney? When to susp...Plasma Cell Dyscrasias & The Kidney (How they affect the kidney? When to susp...
Plasma Cell Dyscrasias & The Kidney (How they affect the kidney? When to susp...
 
High cut off dialysis and multiple myeloma
High cut off dialysis and multiple myelomaHigh cut off dialysis and multiple myeloma
High cut off dialysis and multiple myeloma
 
Tutorial vasculitis
Tutorial vasculitisTutorial vasculitis
Tutorial vasculitis
 
Classification And Diagnosis Of Diabetes
Classification And Diagnosis Of DiabetesClassification And Diagnosis Of Diabetes
Classification And Diagnosis Of Diabetes
 
Urine examination
Urine examinationUrine examination
Urine examination
 
Proteinuria
ProteinuriaProteinuria
Proteinuria
 
Urine examination
Urine examinationUrine examination
Urine examination
 
Proteinuria
ProteinuriaProteinuria
Proteinuria
 
Waldenstroms macroglobulinemia DR MAGDI SASI
Waldenstroms  macroglobulinemia DR MAGDI SASIWaldenstroms  macroglobulinemia DR MAGDI SASI
Waldenstroms macroglobulinemia DR MAGDI SASI
 
Insulin
InsulinInsulin
Insulin
 
Hypoglycemia
HypoglycemiaHypoglycemia
Hypoglycemia
 
Hyperglycemia
HyperglycemiaHyperglycemia
Hyperglycemia
 
Effective Circulating Volume Control - Dr. Gawad
Effective Circulating Volume Control - Dr. GawadEffective Circulating Volume Control - Dr. Gawad
Effective Circulating Volume Control - Dr. Gawad
 
Plasmacytoma
PlasmacytomaPlasmacytoma
Plasmacytoma
 
Insulin presentation
Insulin presentationInsulin presentation
Insulin presentation
 
Urine analysis
Urine analysisUrine analysis
Urine analysis
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
 
Build Features, Not Apps
Build Features, Not AppsBuild Features, Not Apps
Build Features, Not Apps
 

Similaire à Paraproteins and the Kidney

MULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryalMULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryal
Manoj Aryal
 
Multiple myeloma 3
Multiple myeloma  3Multiple myeloma  3
Multiple myeloma 3
Jasmine John
 
Brief Review Of Chemotherapeutic Agents And Renal Failure
Brief Review Of Chemotherapeutic Agents And Renal FailureBrief Review Of Chemotherapeutic Agents And Renal Failure
Brief Review Of Chemotherapeutic Agents And Renal Failure
guest6940925
 
acutepromyelocyticleukemia-
acutepromyelocyticleukemia-acutepromyelocyticleukemia-
acutepromyelocyticleukemia-
icdlab
 

Similaire à Paraproteins and the Kidney (20)

AML ALL HL NHL.pptx
AML ALL HL NHL.pptxAML ALL HL NHL.pptx
AML ALL HL NHL.pptx
 
Minimal change disease
Minimal change diseaseMinimal change disease
Minimal change disease
 
Plasma cell disorders ppt
Plasma cell disorders pptPlasma cell disorders ppt
Plasma cell disorders ppt
 
MULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryalMULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryal
 
Chronic leukemia
  Chronic leukemia    Chronic leukemia
Chronic leukemia
 
Aetiology and management of acute kidney injury in
Aetiology and management of acute kidney injury inAetiology and management of acute kidney injury in
Aetiology and management of acute kidney injury in
 
Acute promyelocytic leukemia
Acute promyelocytic leukemiaAcute promyelocytic leukemia
Acute promyelocytic leukemia
 
Multiple myeloma 3
Multiple myeloma  3Multiple myeloma  3
Multiple myeloma 3
 
Uromodulin
UromodulinUromodulin
Uromodulin
 
Multiple Myeloma (Case presentation)
Multiple Myeloma (Case presentation) Multiple Myeloma (Case presentation)
Multiple Myeloma (Case presentation)
 
multiple myloma.pptx
multiple myloma.pptxmultiple myloma.pptx
multiple myloma.pptx
 
New aphresis prof ehab wafa
New aphresis prof ehab wafaNew aphresis prof ehab wafa
New aphresis prof ehab wafa
 
DCA Poster
DCA PosterDCA Poster
DCA Poster
 
Brief Review Of Chemotherapeutic Agents And Renal Failure
Brief Review Of Chemotherapeutic Agents And Renal FailureBrief Review Of Chemotherapeutic Agents And Renal Failure
Brief Review Of Chemotherapeutic Agents And Renal Failure
 
B cell malignancies and the Kidney
B cell malignancies and the KidneyB cell malignancies and the Kidney
B cell malignancies and the Kidney
 
Aplastic anemia
Aplastic anemiaAplastic anemia
Aplastic anemia
 
acutepromyelocyticleukemia-
acutepromyelocyticleukemia-acutepromyelocyticleukemia-
acutepromyelocyticleukemia-
 
Esa
EsaEsa
Esa
 
aplastic anemia power point presentation
aplastic anemia  power point presentationaplastic anemia  power point presentation
aplastic anemia power point presentation
 
Medicine 5th year, 4th lecture/part one (Dr. Abdulla Sharief)
Medicine 5th year, 4th lecture/part one (Dr. Abdulla Sharief)Medicine 5th year, 4th lecture/part one (Dr. Abdulla Sharief)
Medicine 5th year, 4th lecture/part one (Dr. Abdulla Sharief)
 

Plus de Hofstra Northwell School of Medicine

Plus de Hofstra Northwell School of Medicine (20)

Amacing
AmacingAmacing
Amacing
 
Amacing
AmacingAmacing
Amacing
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
HSCT-TMA
HSCT-TMAHSCT-TMA
HSCT-TMA
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
HSCT-TMA
HSCT-TMAHSCT-TMA
HSCT-TMA
 
Acute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery PatientAcute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery Patient
 
Aki cticu final
Aki cticu finalAki cticu final
Aki cticu final
 
Primary hyperoxaluria and the Kidney
Primary hyperoxaluria and the KidneyPrimary hyperoxaluria and the Kidney
Primary hyperoxaluria and the Kidney
 
Obesity paradox
Obesity paradoxObesity paradox
Obesity paradox
 
Journal Club:Stem cells and Kidney Transplantation
Journal Club:Stem cells and Kidney TransplantationJournal Club:Stem cells and Kidney Transplantation
Journal Club:Stem cells and Kidney Transplantation
 
Proteinuria, A medical student prespective
Proteinuria, A medical student prespectiveProteinuria, A medical student prespective
Proteinuria, A medical student prespective
 
Journal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGSJournal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGS
 
FGF-23 and Mortality in Dialysis patients- Journal Club
FGF-23 and Mortality in Dialysis patients- Journal ClubFGF-23 and Mortality in Dialysis patients- Journal Club
FGF-23 and Mortality in Dialysis patients- Journal Club
 
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
 
Journal Club: Residual renal function
Journal Club: Residual renal functionJournal Club: Residual renal function
Journal Club: Residual renal function
 
Cystic disease of the kidney
Cystic disease of the kidneyCystic disease of the kidney
Cystic disease of the kidney
 
Viruses and the kidney
Viruses and the kidneyViruses and the kidney
Viruses and the kidney
 
Hematuria post transplant
Hematuria post transplantHematuria post transplant
Hematuria post transplant
 

Dernier

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Dernier (20)

Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 

Paraproteins and the Kidney

  • 2.
  • 3. Copyright ©2010 American Society of Hematology. Copyright restrictions may apply. Ghobrial, I. M. et al. ASH-SAP 2010;2010:581-604 Table 20-1 Diagnostic criteria for monoclonal gammopathies
  • 4.
  • 5.  
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14. Copyright ©2006 American Society of Nephrology
  • 15. Protein cast obstructs tubule with syncitial giant cell reaction around it
  • 16.
  • 17. Myeloma cast nephropathy demonstrating light-chain restriction in the casts. Copyright ©2006 American Society of Nephrology Korbet, S. M. et al. J Am Soc Nephrol 2006;17:2533-2545 The cast stained with Ig light chain κ (A) shows bright (3+) staining. The same cast stained in a serial section for light chain λ (B) is negative.
  • 18.
  • 19.  
  • 20.
  • 21. identify FLCs at a minimum concentration of 100-150mg/l. Insufficient to identify non secretory or oligo-secretory myeloma
  • 22. Technique uses purified polyclonal antibodies against free k and λ light chains which are precoated to latex particles and then analyzed by nephlometric assay for quantification. Permits detection of light chain to a level of 2-4mg/l.
  • 23.
  • 24.
  • 25. Median survival 62 mo Median survival 44 mo Median survival 29 mo
  • 26.
  • 27.  
  • 28. EUROPEAN JOURNAL OF CANCER 4 2 ( 2 0 0 6 )
  • 29. Leung et al. KI (2008)
  • 30.
  • 31.
  • 32. Pts got PD in control and HD in PPx group Eleven patients were randomized to receive PLEX. They noted no differences in the overall renal recovery rate however, in a subgroup analysis of the dialysis patients, renal recovery occurred only in those who received PLEX. Small study. compromised by the use of a composite outcome which disadvantaged PLEX because patient who died with improved renal function and those with eGFR <30 were considered failures. the renal pathology was not verified due to the low biopsy rate. Finally, no method was employed to assess the adequacy of treatment.
  • 33.
  • 34.
  • 35.  
  • 36.
  • 37.  
  • 38.
  • 39.
  • 40.
  • 41.
  • 42. Mesangial & Cap loops amyloid deposits. Arteriolar wall with amyloid.
  • 44. www.pathology.vcu.edu IMMUNOHISTOCHEMICAL STAININGS To differentiate amyloid AL and AA, specific antibodies can also be used.
  • 45. Copyright ©2006 American Society of Nephrology randomly arranged, nonbranching fibrils with an average diameter of 90 to 110 Å Renal amyloidosis, ultrastructural appearance
  • 46. www.pathology.vcu.edu Amyloid p glycoprotein component present in basement membrane binds the amyloid fibrils
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.  
  • 52.  
  • 53.
  • 54.
  • 55.
  • 56. Copyright ©2006 American Society of Nephrology Korbet, S. M. et al. J Am Soc Nephrol 2006;17:2533-2545 Monoclonal Ig deposition disease (MIDD) with diffuse and nodular glomerulosclerosis
  • 57. Copyright ©2006 American Society of Nephrology Korbet, S. M. et al. J Am Soc Nephrol 2006;17:2533-2545 MIDD showing light chain restriction by immunofluorescence microscopy
  • 58. inconstant electron-dense, subendothelial, granular, punctuate deposits that may diffusely infiltrate the basal lamina.
  • 59.
  • 60.
  • 61.